Skip to main content
RENHE PHARMACY CO.,LTD logo

RENHE PHARMACY CO.,LTD — Investor Relations & Filings

Ticker · 000650 ISIN · CNE000000NF8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,739 across all filing types
Latest filing 2025-08-25 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000650

About RENHE PHARMACY CO.,LTD

https://www.renheyaoye.com

Renhe Pharmacy Co., Ltd. specializes in the research, development, manufacturing, and distribution of pharmaceutical products and health-related commodities. The company maintains a diverse portfolio encompassing over-the-counter (OTC) medications, traditional Chinese medicines (TCM), health supplements, and personal care items. Its core product lines address various therapeutic areas, including respiratory health, digestive disorders, gynecology, and pediatrics. Renhe is recognized for its established brand equity, operating well-known labels such as Renhe, Youka, and Fuyan. The company integrates modern pharmaceutical technology with traditional medicinal practices to produce high-quality healthcare solutions. Its operations are supported by a comprehensive supply chain and an extensive marketing network, focusing on providing accessible healthcare products to a broad consumer base.

Recent filings

Filing Released Lang Actions
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2025 年半年度报告摘要' which translates to '2025 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also includes shareholder information and other company details relevant to the half-year period. The length of the document (6417 characters) and the presence of substantive financial data indicate this is a comprehensive interim financial report rather than a brief announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-25 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 95% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the first half of 2025. It includes specific financial figures such as balances, amounts occupied, interest, repayments, and the nature of the transactions. The content is financial and operational data related to intercompany and related party transactions, typical of disclosures in interim or quarterly financial reports. There is no indication that this is an announcement or a brief summary; the document contains substantive financial data for a half-year period. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-25 Chinese
半年报监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 10th Supervisory Board's second meeting of Renhe Pharmaceutical Co., Ltd. It includes approval of the company's 2025 semi-annual report and a special report on the use of raised funds. The document states that the full semi-annual report and the special report are published separately on the CNINFO website, indicating this document itself is not the report but an announcement of the meeting resolutions and approvals. The document length is short (1055 characters), and it primarily serves as a disclosure of meeting decisions rather than containing the full financial report or detailed financial data. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or Annual Report (10-K).
2025-08-25 Chinese
半年报董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 10th Board of Directors' second meeting of Renhe Pharmaceutical Co., Ltd. It includes approval of the company's 2025 semi-annual report and a special report on the use and storage of raised funds. The document states that the full semi-annual report and the special report are published separately on an external website (cninfo.com.cn). The document itself does not contain the actual financial statements or detailed report content but rather announces the board's approval of these reports and the voting results. The document length is short (1088 characters), and it serves as a meeting resolution announcement rather than the report itself. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not contain full financial reports.
2025-08-25 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Renhe Pharmaceutical Co., Ltd. It discusses unusual stock price movements over two trading days, clarifies the company's operational status, and addresses rumors about a new product. It explicitly states that no undisclosed material information exists and provides a risk warning to investors. The document is a regulatory announcement related to stock price behavior and investor information, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. The document length is short (1395 characters), and it is an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-21 Chinese
电子邮箱变更公告
Regulatory Filings Classification · 100% confidence The document is a short announcement regarding the change of the company's email address for investor contact. It contains no financial data, no report or meeting information, and no regulatory or legal content beyond the contact update. The length is only 428 characters, indicating it is a brief notice. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2025-06-19 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.